volume 469, issue 5, P523-532 2016
DOI: 10.1007/s00428-016-2014-x
View full text
|
|
Share
Olca Basturk, Sun M. Chung, Ralph H. Hruban, N. Volkan Adsay, Gokce Askan, Christine Iacobuzio-Donahue, Serdar Balci, Sui Y. Zee, Bahar Memis, Jinru Shia, David S. Klimstra

Abstract: Intraductal oncocytic papillary neoplasm(IOPN) of the pancreas is classified as a variant of intraductal papillary mucinous neoplasm(IPMN) in the WHO guidelines. However, the neoplastic cells of IOPNs are unique, with distinctive architecture/oncocytic cytoplasm. Although molecular/immunohistochemical features of other IPMN variants have been extensively studied, those of IOPNs have not been well characterized. Expression profile of antibodies associated with genetic alterations previously described for ducta…

expand abstract